Design and evaluation of a multi-epitope assembly Peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice

Virology Journal

Volumn 8, Issue , 2011, Pages

  Wang, Xingsheng ^a   Xie, Guangyan ^c   Liao, Jianming ^b   Yin, Dengke ^c   Guan, Wenyan ^a   Pan, Mingjie ^a   Li, Jingnian ^d   Li, Yuexi ^a  

^a HUADONG RESEARCH INSTITUTE FOR MEDICINE AND BIOTECHNICS   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^d ANHUI AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN B2; GLYCOPROTEIN C2; GLYCOPROTEIN D; GLYCOPROTEIN D2; GLYCOPROTEIN E2; GLYCOPROTEIN G2; GLYCOPROTEIN I2; MULTI EPITOPE ASSEMBLY PEPTIDE; NEUTRALIZING ANTIBODY; PROTEIN C; THROMBOSPONDIN; UNCLASSIFIED DRUG; HERPES VACCINE; RECOMBINANT VACCINE; SUBUNIT VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG ANTIGENICITY; DRUG DESIGN; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HERPES SIMPLEX VIRUS 2 INFECTION; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; GENETICS; IMMUNOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HERPESVIRUS VACCINES; MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 79955802288     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-232     Document Type: Article

References (32)

1. Challenges in genital herpes simplex virus management. L Corey, J Infect Dis 2002 186 Suppl. 1 29 S33 12353184
2. Recent progress in herpes simplex virus immunobiology and vaccine research. DM Koelle L Corey, Clin Microbiol 2003 16 96 113 10.1128/CMR.16.1.96- 113.2003 (Pubitemid 36114709)
3. Herpes simplexvirus infections. RJ Whitley B Roizman, Lancet 2001 35 1513 1518
4. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. J Akhtar D Shukla, FEBS J 2009 276 7228 36 10.1111/j.1742-4658. 2009.07402.x 19878306
5. The herpesvirus glycoproteins B and H/L are sequentially recruited to the receptor bound gD to effect membrane fusion at virus entry. T Gianni C Forghieri G Campadelli-Fiume, Proc Natl Acad Sci 2006 103 14572 7 10.1073/pnas.0606127103 16973744 (Pubitemid 44484791)
6. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. PE Pertel A Fridberg ML Parish PG Spear, Virology 2001 279 313 32 10.1006/viro.2000.0713 11145912
7. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. C Krummenacher VM Supekar JC Whitbeck E Lazear SA Connolly RJ Eisenberg GH Cohen DC Wiley A Carfi, EMBO J 2005 24 4144 4153 10.1038/sj.emboj.7600875 16292345 (Pubitemid 41752883)
8. Spear PG Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. PE Pertel A Fridberg ML Parish, Virology 2001 279 313 324 10.1006/viro.2000.0713 11145912 (Pubitemid 34161021)
9. Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins. J Sollne R Grohmann R Rapberger P Perco A Lukas B Mayer, Immunome Research 2008 4 1 10.1186/1745-7580-4-1 18179690
10. Peptide Based Vaccine Design: Synthesis and Immunological Characterization of Branched Polypeptide Conjugates Comprising the 276-284 Immunodominant Epitope of HSV-1 Glycoprotein D. G Mezo B Dalmadi I Mucsi S Bosze E Rajnavölgyl F Hudecz, Journal of Peptide Science 2002 8 107 117 10.1002/psc.373 11931583 (Pubitemid 34211183)
11. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. H Ghiasi S Cai GC Perng AB Nesburn SL Wechsler, Br J Ophthalmol 2008 84 408 412
12. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. AP Haste M Nielsen O Lund, Protein Science 2006 15 2558 2567 10.1110/ps.062405906 17001032 (Pubitemid 44771693)
13. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. R Kaur G Sachdeva S Vrati, J Infect Dis 2002 185 1 12 10.1086/338015 11756975 (Pubitemid 34043010)
14. Expression of the HSV-1glycoprotein B gene in insect cells infected by HcNPV recombinant. H Cha SC. Kang SY Lee GJ Park HH Lee, J Microbiol Biotechnol 2000 10 355 362 (Pubitemid 30490589)
15. High level production of glycoprotein protein H of the HSV-1(F) using HcNPV vector system. H Kang SC Cha YJ Han IH Park MJ Lee SM Byun HH Lee, J Biochem Mol Biol 2000 33 483 492
16. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of Herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice. HJ Geerligs H Clemens M Kocken JW Drijfhout WJ Weijer W Bloemhoff JB Wilterdink W Welling S Welling-Wester, Journal of General virology 1990 71 1767 1774 10.1099/0022-1317-71-8-1767 2167930 (Pubitemid 20248442)
17. Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B: H: L gene DNAs. SC Cha YS Kim JK Cho J Cho SY Kim H Kang MH Cho HH Lee, Virus Res 2002 86 21 31 10.1016/S0168-1702(02) 00037-0 12076826 (Pubitemid 34655570)
18. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1. S Khattar KPL Collins SK Samal, Vaccine 2010 28 3159 70 10.1016/j.vaccine.2010.02.051 20189484
19. Immunization with combined HSV-2 glycoproteins B2: D2 gene DNAs: protection against lethal intravaginal challenges in mice. HH Lee SC Cha DJ Jang JK Lee DW Choo YS Kim HS Uh SY Kim, Virus Genes 2002 25 179 88 10.1023/A:1020113902834 12416680 (Pubitemid 35192105)
20. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. A Simmons AA Nash, J Virol 1984 52 816 21 6092713 (Pubitemid 15216305)
21. Hage-Hamsten, Rational design of hypoallergens applied to the major cat allergen Fel d 1. T Saarne L Kaiser H Gronlund O Rasool G Gafvelin M Van, Clin Exp Allrgy 2005 35 657 663 10.1111/j.1365-2222.2005.02234.x (Pubitemid 40769292)
22. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. A Sette J Fikes, Curr Opin Immunol 2003 15 461 470 10.1016/S0952-7915(03)00083-9 12900280 (Pubitemid 36934509)
23. Developing an epitope-driven tuberculosis (TB) vaccine. AS Groot De J McMurry J Franco D Rivera M Kutzler D Weiner B Martin, Vaccine 2005 23 2121 2131 10.1016/j.vaccine.2005.01.059 15755582 (Pubitemid 40341438)
24. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice. JS Burgos E Serrano-Saiz I Sastre F Valdivieso, J Neurovirol 2006 12 420 7 10.1080/13550280601009546 17162658 (Pubitemid 44911563)
25. + T-cell. B Wang K Yao G Liu F Xie F Zhou Y Chen, Cellular & Molecular Immunology 2009 6 97 103 10.1038/cmi.2009.13 21584949
26. Development of a recombinant vaccine against Japanese encephalitis. R Kaur S Vrati, J Neurovirol 2003 9 421 431 12907387 (Pubitemid 36986809)
27. Pep-3D-Search: a method for B-cell epitope prediction based on mimotope analysis. YX Huang YL Bao SY Guo Y Wang CG Zhou YX Li, BMC Bioinformatics 2008 9 5381 5387
28. Alessandro Sette and Bjoern Peters Software EIIiPro: a new structur-based tool for the prediction of antibody epitopes. J Ponomarenko W Huynh-Hoa Bui N Li P Fusseder E Bourne, BMC Bioinformatics 2008 9 5141 5148
29. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. M Shirai CD Pendleton J Ahlers T Takeshita M Newman JA Berzofsky, J Immunol 1994 152 549 556 8283036 (Pubitemid 24072958)
30. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta]. K Bharati R Rani S Vrati, Vaccine 2009 27 10 16 10.1016/j.vaccine.2008.10.050 18996161
31. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodes. J Kimura-Kuroda K Yasui, J Immunol 1998 141 3606 3610
32. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitic virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. K Murali-Krishna V Ravi R Manjunath, J Gen Virol 1996 77 Pt 4 705 714 8627259